WS-SK TARGET (08427) plans to offer a discount of approximately 14.61% for the issuance of 216,000 shares, with a net proceeds of approximately 4.2399 million Hong Kong dollars.
Wanshun Ruiqiang Group (08427) announced that on December 3, 2025, the company plans to issue and issue 216,000 shares to the subscriber (Mr. Cai Shangqi), equivalent to approximately 1.30% of the issued share capital of the company after the expansion of the subscribed shares. The subscription price for each share is HK$19.93, representing a discount of approximately 14.61% compared to the closing price of HK$23.34 per share on December 3. The total amount expected to be raised from the subscription is approximately HK$43.05 million. The expected net amount to be raised from the subscription is approximately HK$42.399 million. The company plans to use the net proceeds from the subscription for general operating expenses. The directors believe that the subscription will enable the group to raise funds to strengthen its financial position.
WS-SK TARGET (08427) announced that on December 3, 2025, the company intends to issue and distribute 216,000 shares to the subscriber (Mr. Cai Shangqi), representing approximately 1.30% of the enlarged issued share capital of the company after the issuance. The subscription price for each share is HK$19.93, which is a discount of approximately 14.61% compared to the closing price of HK$23.34 on December 3. The total expected proceeds from the subscription are approximately HK$43.05 million, with an expected net amount of approximately HK$42.399 million. The company plans to use the net proceeds from the subscription for general operating funds. The directors believe that the subscription will enable the group to raise funds to strengthen its financial position.
Related Articles

On December 3rd, EDIANYUN (02416) spent 345,000 Hong Kong dollars to repurchase 158,500 shares.

HENLIUS (02696) signed a cooperation agreement with Aohong Pharmaceutical on folic acid citrate capsules.

Nanhua Instruments (300417.SZ) shareholders plan to reduce their holdings by a total of no more than 1.19%.
On December 3rd, EDIANYUN (02416) spent 345,000 Hong Kong dollars to repurchase 158,500 shares.

HENLIUS (02696) signed a cooperation agreement with Aohong Pharmaceutical on folic acid citrate capsules.

Nanhua Instruments (300417.SZ) shareholders plan to reduce their holdings by a total of no more than 1.19%.






